VRTX Competitors
Vertex Pharmaceuticals Incorporated
$507.00
-$3.08(-0.60%)
61
Overall
60
Value
60
Tech
63
Quality
Market Cap
$129.29B
Volume
939.96K
52W Range
$402.58 - $560.25
Target Price
$572.86
VRTX competitors: GILD, ABBV, JNJ, BMY, MRK. Vertex Pharmaceuticals Incorporated is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
VRTX Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| GILD Gilead Sciences, Inc. | $150.43 | $187.44B | $-0.47 | 2.16% | 73 |
| ABBV AbbVie Inc. | $281.04 | $488.55B | $13.94 | 2.43% | 64 |
| JNJ Johnson & Johnson | $263.12 | $630.04B | $11.18 | 2.01% | 50 |
| BMY Bristol-Myers Squibb Company | $57.53 | $120.77B | $6.80 | 3.29% | 55 |
| MRK Merck & Co., Inc. | $145.60 | $359.22B | $2.66 | 2.34% | 74 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRTX | $507.00 | -0.6% | 939.96K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Vertex Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW